Dr. Zoe Eloise Quandt, MD

Dr. Quandt practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Quandt's NPI, 1861735714, was assigned on March 28, 2013. Dr. Quandt graduated from UCSF School of Medicine in 2013. Dr. Quandt holds California license A131799.

Dr. Quandt's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Quandt's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Quandt to 3 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Quandt practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Quandt's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Quandt is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dr. Quandt is licensed in California.

Dmand AI lists chronic diabetes, diabetic emergency, obesity, osteoporosis, overactive thyroid, parathyroid gland disorder, testicular dysfunction and underactive thyroid among the conditions Dr. Quandt treats.

CMS data shows 136 Medicare services from Dr. Quandt across 3 procedure codes in 2024, for 87 Medicare patients. Medicare paid $13,066 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 87 Medicare patients who saw Dr. Quandt in 2024. The largest group is 65 to 74, with 39 patients. 74% of them have high cholesterol, and 71% have high blood pressure. 26% are also on Medicaid. Their average risk score is 3.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Quandt's median patient age at 66, with 64% women.

In 2024, Dr. Quandt wrote 367 Medicare Part D claims for 55 patients. 47% of them were for generic drugs. CMS names the drug for 212 of them, across 7 drugs with 11 or more claims each, at $19,841 in total drug cost. In 2023, CMS named 154 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Quandt for performance year 2024, reported as part of a group. Dr. Quandt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Quandt as offering telehealth.

Dmand AI links 30 papers to Dr. Quandt, published from 2015 to 2025. 2023 was the busiest year, with 5. The most frequent topics are Diabetes Mellitus, Type 1, Immune Checkpoint Inhibitors and Autoimmunity. Dr. Quandt has published most often in Diabetes. Dr. Quandt's most frequent co-authors are Mark S. Anderson, MD, Alice Chan, MD and Robert J. Rushakoff, MD.

CMS Open Payments shows 24 general payments to Dr. Quandt from 3 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 91% of the total. Sanofi and Genzyme US Companies paid the most, $13,495. It also lists 5 research payments totaling $7,345 from 2022 to 2024.

Dr. Quandt graduated from UCSF School of Medicine in 2013.

Dr. Quandt is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.